Target intelligence / Profile preview

Basic leucine zipper and W2 domain-containing protein 2 (BZW2)

Target
BZW2
Molecular classification
Translation regulatory protein, Transcription factor (original designation, now considered inaccurate), Leucine zipper superfamily, eIF5 mimetic protein, Other (due to unique translation regulatory role)
01

Overview

Basic leucine zipper and W2 domain-containing protein 2 (BZW2) is a cytoplasmic protein encoded by the BZW2 gene, highly conserved from bacteria to mammals. Its primary structure features a leucine zipper motif followed by an eIF5C domain, making it a member of the basic-region leucine zipper superfamily and an eIF5 mimetic. BZW2 regulates translation initiation by competing with eIF5 for eIF2 interaction; this influences start codon selection and ensures preference for canonical translation start sites (AUG). In oncogenesis, BZW2 is upregulated in multiple malignancies and promotes tumor growth, migration, invasion, and resistance to apoptosis via activation of oncogenic signaling pathways (c-Myc, AKT/mTOR, Wnt/β-catenin). BZW2 also interacts with viral proteins such as SARS-CoV-2 nsp8, suggesting roles in host-pathogen interaction. Its broad physiological function and implication in disease make BZW2 a promising, though challenging, candidate for therapeutic intervention and biomarker development[1][2][3][4][5].

Other names
eIF5-mimic protein 15MP1HSPC028MST017MSTP017Basic leucine zipper and W2 domains 2Eukaryotic translation factor 5
02

Mechanism of action

Translation inhibition via competition with eIF5 for eIF2 binding; Regulation of canonical versus non-canonical start site translation; Oncogenic cascade modulation by promoting degradation of GSK3β, activating Wnt/β-catenin; Upregulation of c-Myc and multiple growth-promoting pathways.

03

Biological functions

Translation initiation regulationCompetitive inhibitor of eIF5 activityStringency control of start codon selection (prefers canonical AUG over non-AUG)Regulation of oncogenic signaling pathways (e.g., c-Myc, AKT/mTOR, Wnt/β-catenin)Cell proliferationCell migration and invasion (promotes malignant behavior)Apoptosis regulationHomeostasis of non-AUG translatome
04

Disease associations

Cancer (hepatocellular carcinoma, lung adenocarcinoma, colorectal cancer, muscle-invasive bladder cancer, osteosarcoma, fibrosarcoma)Infection (SARS-CoV-2 interaction)Other (potential indirect roles in inflammation and metastasis through key pathways)
05

Safety considerations

Targeting BZW2 may affect global translation and fundamental cellular protein synthesis, posing potential risk for broad cytotoxicity or unwanted effectsPotential for resistance or compensatory changes due to redundancy with paralog BZW1High tissue ubiquity could mean off-target toxicities
06

Biomarkers

BZW2 overexpression described as a prognostic biomarker for severity, recurrence, and outcome in several cancers (lung adenocarcinoma, hepatocellular carcinoma, colorectal cancer)Associated downstream effects (e.g., c-Myc upregulation, AKT/mTOR activation) may serve as indirect biomarkers

Beyond the preview

Go deeper on Basic leucine zipper and W2 domain-containing protein 2 (BZW2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic leucine zipper and W2 domain-containing protein 2 (BZW2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call